27 phenotypes from multigenic genotypes

Allelic Composition Genetic Background	Annotated Term	Reference
Bcl2l11tm1.1Ast/Bcl2l11tm1.1Ast Dicer1tm1Mmk/Dicer1tm1Mmk Cd79atm1(cre)Reth/Cd79a+ involves: 129S1/Sv * BALB/c	decreased B cell number	J:135783
	decreased mature B cell number	J:135783
Bcl2l11tm1Ast/Bcl2l11tm1Ast Dicer1tm1Bdh/Dicer1tm1Bdh Aicdatm1(cre)Njen/Aicda+ involves: 129S1/Sv * C57BL/6	abnormal B cell differentiation	J:181782
	decreased germinal center B cell number	J:181782
	decreased plasma cell number	J:181782
Cd79atm1(cre)Reth/Cd79a+ Dicer1tm1Mmk/Dicer1tm1Mmk Tg(BCL2)22Wehi/0 involves: BALB/c * C57BL/6JWehi * SJL/JWehi	decreased B cell number	J:135783
	decreased mature B cell number	J:135783
Cdkn2atm1Rdp/Cdkn2atm1Rdp Dicer1tm1Snj/Dicer1tm1Snj involves: 129/Sv * 129S7/SvEvBrd * C57BL/6 * SJL	increased cell proliferation	J:139257
Cdkn2atm1Rdp/Cdkn2atm1Rdp Dicer1tm1Snj/Dicer1tm1Snj involves: 129/Sv * 129S7/SvEvBrd * C57BL/6 * SJL	normal cellular phenotype	J:139257
Dicer1tm1.1Doca/Dicer1tm1.1Doca involves: 129P2/OlaHsd * BALB/cJ * C57BL/6	no abnormal phenotype detected	J:228491
Dicer1tm1Bdh/Dicer1+ Yy1tm2.1Yshi/Yy1+ Shhtm1(EGFP/cre)Cjt/Shh+ involves: 129 * 129S4/SvJae * C57BL/6	normal respiratory system phenotype	J:239777
Dicer1tm1Mmk/Dicer1tm1Mmk Fgf9tm1.1Fwan/Fgf9+ Shhtm1(EGFP/cre)Cjt/Shh+ involves: 129 * 129S4/SvJaeSor * C57BL/6J	normal respiratory system phenotype	J:224791
Dicer1tm1Mmk/Dicer1tm1Mmk Fgf9tm1.1Fwan/Fgf9tm1.1Fwan Shhtm1(EGFP/cre)Cjt/Shh+ involves: 129 * 129S4/SvJaeSor * C57BL/6J	normal respiratory system phenotype	J:224791
Dicer1tm1Mmk/Dicer1tm1Mmk Tg(IghelMD4)4Ccg/0 Cd79atm1(cre)Reth/Cd79a+ involves: BALB/c	decreased B cell number	J:135783
	decreased mature B cell number	J:135783
Dicer1tm1Snj/Dicer1tm1Snj Trp53tm1Brd/Trp53tm1Brd involves: 129S7/SvEvBrd * C57BL/6	increased cell proliferation	J:139257
Dicer1tm1Snj/Dicer1tm1Snj Trp53tm1Brd/Trp53tm1Brd involves: 129S7/SvEvBrd * C57BL/6	normal cellular phenotype	J:139257
Dicer1tm1Snj/Dicer1tm1Snj Trp53tm1Brn/Trp53+ Tg(KRT5-cre/PGR)1Der/0 involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6N * FVB/N * ICR	increased basal cell carcinoma incidence	J:216813
	increased skin tumor incidence	J:216813
	premature death	J:216813
Dicer1tm1Snj/Dicer1tm1Snj Trp53tm1Brn/Trp53tm1Brn Tg(KRT5-cre/PGR)1Der/0 involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6N * FVB/N * ICR	abnormal epidermis stratum basale morphology	J:216813
	abnormal hair cycle	J:216813
	abnormal hair follicle morphology	J:216813
	abnormal hair shaft morphology	J:216813
	abnormal skin physiology	J:216813
	hypergranulosis	J:216813
	increased skin squamous cell carcinoma incidence	J:216813
	increased skin tumor incidence	J:216813
	premature death	J:216813
	progressive hair loss	J:216813
	thick epidermis	J:216813
Dicer1tm1Tara/Dicer1tm1Tara Ptentm1Hwu/Ptentm1Hwu Amhr2tm3(cre)Bhr/Amhr2+ involves: 129P2/OlaHsd * 129S4/SvJae * 129S7/SvEvBrd	abnormal oviduct morphology	J:182161
	ascites	J:182161
	increased carcinoma incidence	J:182161
	increased metastatic potential	J:182161
	increased ovarian carcinoma incidence	J:182161
	premature death	J:182161
Dicer1tm1Tara/Dicer1tm1Tara Ptentm1Hwu/Ptentm1Hwu Trp53tm2Tyj/Trp53+ Amhr2tm3(cre)Bhr/Amhr2+ involves: 129P2/OlaHsd * 129S4/SvJae * 129S7/SvEvBrd	ascites	J:222579
	increased carcinoma incidence	J:222579
	increased metastatic potential	J:222579
	increased ovarian carcinoma incidence	J:222579
	premature death	J:222579
Dicer1tm1Tara/Dicer1tm1Tara Trp53tm2Tyj/Trp53+ Amhr2tm3(cre)Bhr/Amhr2+ involves: 129P2/OlaHsd * 129S4/SvJae * 129S7/SvEvBrd	normal neoplasm	J:222579